ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0716

Afucosylated IgG in Patients with Idiopathic Nephrotic Syndrome and Antinephrin Autoantibodies Correlates with Disease Activity

Session Information

Category: Pediatric Nephrology

  • 1900 Pediatric Nephrology

Authors

  • Lugani, Francesca, Istituto Giannina Gaslini, Genoa, Liguria, Italy
  • Spinelli, Sonia, Istituto Giannina Gaslini, Genoa, Liguria, Italy
  • La Porta, Edoardo, Istituto Giannina Gaslini, Genoa, Liguria, Italy
  • Rumeo, Noemi, Istituto Giannina Gaslini, Genoa, Liguria, Italy
  • Granata, Simona, Universita della Calabria, Arcavacata di Rende, Calabria , Italy
  • Gallon, Lorenzo G., University of Illinois Chicago College of Medicine, Chicago, Illinois, United States
  • Zaza, Gianluigi, Universita della Calabria, Arcavacata di Rende, Calabria , Italy
  • Verrina, Enrico E., Istituto Giannina Gaslini, Genoa, Liguria, Italy
  • Bruschi, Maurizio, Universita degli Studi di Genova, Genoa, Liguria, Italy
Background

Idiopathic nephrotic syndrome (INS) is a glomerular disorder characterized by podocyte injury and proteinuria. Emerging evidence suggests that anti-nephrin autoantibodies (Abs) may contribute to disease pathogenesis in a subset of INS patients. However, variation in detection techniques and lack of urinary data have limited the reproducibility and interpretation of results. Additionally, while reduced IgG fucosylation enhances antibody-dependent cellular cytotoxicity in non-INS autoimmune diseases, its modulating anti-nephrin autoantibody function and disease severity in INS remains unexplored.

Methods

We analyzed serum and urine samples from pediatric and young adult patients with biopsy-proven focal segmental glomerulosclerosis (FSGS) or minimal change disease (MCD), stratified by disease activity (proteinuria-positive vs proteinuria-negative). Anti-nephrin Abs were assessed using conventional ELISA and immunoprecipitation with recombinant full-length FLAG-tagged human nephrin. The fucosylation profile of IgG autoantibodies was analyzed using Aleuria aurantia lectin (AAL) and Ulex europaeus agglutinin I (UEA-I).

Results

Anti-nephrin autoantibodies were detected in 11% of FSGS and 15% of MCD patients, with higher prevalence among those with nephrotic-range proteinuria. These autoantibodies were absent in healthy controls and in patients with membranous nephropathy or lupus nephritis. Autoantibody titers correlated with disease activity, decreasing during remission. ELISA and immunoprecipitation provided consistent results. In a subset of anti-nephrin-positive patients, antibodies were also detected in urine. Circulating anti-nephrin IgG exhibited significantly reduced antennary and core fucosylation.

Conclusion

Our findings confirm that anti-nephrin autoantibodies are associated with active disease in a subset of INS patients and can also be detected in urine. The correlation between ELISA and immunoprecipitation supports assay reliability. Importantly, altered IgG fucosylation may enhance the pathogenicity of anti-nephrin autoantibodies, providing mechanistic insights and identifying potential biomarkers and therapeutic targets in INS.

Funding

  • Government Support – Non-U.S.

Digital Object Identifier (DOI)